Objectives To determine the excess risk of non-chromosomal congenital anomaly (NCA) among teenage mothers and older mothers.
Introduction
It is well known that older mothers have a higher risk of chromosomal anomalies such as Down syndrome, 1,2 but whether they are at excess risk of non-chromosomal congenital anomalies (NCA) is less clear. At the other end of the maternal age spectrum, teenage mothers have a low risk of chromosomal trisomy, but a higher risk of some NCA, 3 in particular the abdominal wall defect gastroschisis. [4] [5] [6] Maternal age may be an indicator of intrinsic biologic factors and previous reproductive history (including parity) or extrinsic factors, such as education, nutritional status or social and behavioural influences. If maternal age risks are related to extrinsic factors rather than intrinsic biological factors, they can be expected to vary both geographically and in time. Risk may be associated with current or past exposures. Cohorts of mothers may differ in risk according to the year they were born rather than their age at delivery. Advanced maternal age may also be associated with a differentially increased risk of miscarrying an affected fetus.
In the last two decades, the maternal age profile of the population has changed markedly in Europe, with average maternal age rising each year. It is important to have accurate information on maternal age-specific risks of NCA to gauge the implications of this rise in maternal age for public health, for clinical care needs and for providing information to women of childbearing age. Some of the older literature on maternal age risks is difficult to interpret, since it is likely that chromosomal anomalies in babies with structural malformations were underdiagnosed, thus creating artefactually increased risks for older mothers of apparently non-chromosomal anomalies. 7 Many studies have been too small to consider mothers over 40 specifically, or to provide precise estimates for specific types of NCA.
The persistent high rate of teenage pregnancy in some European populations is of continuing concern, 8, 9 especially its relationship with deprivation and unplanned pregnancy. 10, 11 This group experiences poorer pregnancy outcomes overall 12, 13 due both to their unfavourable environment and biologic immaturity.
14 There is little information from Europe on the overall risk of NCA in teenage mothers.
EUROCAT is a network of population-based congenital anomaly registers covering nearly one-third of births in Europe, with a standardised methodology. In this paper, we analyse the EUROCAT database to determine maternal age-specific risks of NCA.
Method
The EUROCAT database consists of all cases of congenital malformations notified by regional or national registries including live born cases, cases resulting in fetal deaths from 20 weeks gestation and cases that were subsequently terminated following prenatal diagnosis of a congenital malformation. Twenty-three regional registries in 15 European countries participated in the study, all of which could provide maternal age data for both cases and population, for the period 2000-2004. Information on each of the registries and their methods of case ascertainment can be found on the EUROCAT website. 15 Maternal age was defined as age at delivery of baby and was known for 97% of NCA cases. The remaining 3% of cases with unknown maternal age were excluded.
Congenital anomaly cases are coded within the range 740-759 in ICD9 or the Q chapter in ICD10 code (International Classification of Disease). One case can have up to nine malformation or syndrome codes. The EUROCAT Data Management Program (EDMP) automatically assigns all congenital anomaly codes to one of 84 EUROCAT NCA subgroups (see 'EUROCAT Guide 1.3: Instructions for the registration and surveillance of congenital anomalies' for the list of subgroups and codes). 16 A case can be counted only once in each subgroup but may be counted within more than one subgroup. All cases with a diagnosis coded within ICD9/BPA 758.00-758.99 and ICD10 Q90.0-Q99.9, excluding microdeletions and balanced translocations, are classified as chromosomal anomalies and excluded from this study. For comparative purposes only, a dataset of these chromosomal cases was extracted for the same registries and time period in order to calculate the maternal age-specific prevalence of chromosomal cases.
The number of births (live and still) by maternal age group was supplied by the participating registries, obtained from appropriate statistical agencies or hospitals within the areas. Maternal age was known for 97% of births in the study population. The remaining 3% were assumed to follow the same maternal age distribution as those of known maternal age, within each registry and year. A Poisson regression model using STATA version 9.0 (StataCorp LP, College Station, TX, USA) was used to derive maternal age-specific relative risks (RR) relative to the 25-to 29-year age group baseline. This baseline group was chosen as it is in the middle of the age range (one age category removed from ages <20 and over 35) and is commonly used as a standard baseline in the literature. A model for all NCA first adjusting for country was fitted. Adjustment for country was designed to adjust for the possibility that countries with high proportions of mothers in any one age group also had generally high NCA prevalence, and that this would bias the RR estimates between age groups. A second model, after excluding mothers 45+, allowed for interaction between country and maternal age using the UK as an arbitrary baseline country. We give country-specific results by multiplying the UK RR by the country-specific RR for each maternal age group. A third model for each of the 84 NCA subgroups adjusting for country was fitted, which did not allow for interactions due to the lack of statistical power. Because of the large number of subgroups and the problem of spuriously statistically significant results by multiple testing, only NCA subgroups with significantly increased risk at P < 0.01 level are presented in the Results. Full results for all 84 subgroups are available online in the Appendix (S1). Risk estimates for the mothers 45+ years are not shown where small numbers led to very large standard errors (Appendix S1). Maternal age was modelled as a categorical variable in order to investigate maternal age risk curves of any shape.
Statistical analysis

Results
Maternal age population distribution
Overall in 2000-2004, 4% of mothers in the population were aged <20 years, 14% were aged 20-24 years, 28% were aged 25-29 years, 34% were aged 30-34 years, 17% were aged 35-39 years, 3% were 40-44 years and 0.14% were aged 45 years and older. These proportions are generally consistent with the European Union maternal age distribution based on EUROSTAT figures for livebirths in the same countries and time period.
17 Table 1 shows the geographical variation in the proportion of younger (<20 years) and older mothers (40+ years) between countries, 2000-2004. The proportion of teenage mothers ranged from <2% in France, Italy, the Netherlands, Spain and Switzerland to 9% in the UK. The proportion of mothers 35 years and over ranged from 9% in Poland to 25%-28% in France, Italy and Spain. The proportion of mothers 40 years and over ranged from <2% in Belgium, Croatia, Denmark, Germany and Poland to 6% in France. A model including interaction between maternal age and country was found to provide a significantly better fit (P < 0.001). In the UK (baseline country), the risk of NCA was 1.09 in teenage mothers, 0.96 in mothers 35-39 and 1.06 in mothers 40-44 years ( Table 3 shows the specific NCAs for which teenage mothers had significantly increased risk (P < 0.01) compared with mothers aged 25-29. Teenage mothers were six times more likely to have a baby with gastroschisis (RR 6.32, 95% CI 4.75-8.41) and almost five times more likely to have malformations resulting from three maternal infections [congenital rubella, congenital cytomegalovirus (CMV) and congenital toxoplasmosis] during the first trimester of pregnancy (RR 4.57, 95% CI 2.24-9.32) compared with 25-to 29-year-old mothers. Teenage mothers had a nearly three-fold greater risk of having a baby with tricuspid atresia and stenosis (RR = 2.63, 95% CI 1.37-5.06) compared with baseline mothers. Teenage mothers were also at greater risk of having a baby with anencephalus (RR = 1.74, 95% CI 1.22-2.47), nervous system anomalies (RR 1.39, 95% CI 1.20-1.61), digestive system anomalies (RR = 1.31, 95% CI 1.09-1.57) and abdominal wall defects (RR 3.52 95% CI 2.80-4.44). A 'U-shaped' distribution curve with younger and older mothers showing significantly increased risk was reported for respiratory anomalies (P < 0.001) (Appendix S1). Teenage mothers had a 50% increased risk of having babies with respiratory anomalies while mothers over 40 years had a 43% increased risk compared with 25-to 29-year-old mothers (Appendix S1).
Maternal age prevalence and risk
The Appendix lists the RR for all NCA subgroups according to maternal age compared with women aged 25-29, together with the statistical significance of any maternal age effect. As a large numbers of comparisons are being made there will be spurious statistically significant results and therefore care must be taken in interpreting individual statistically significant results.
Discussion
Overall in Europe, we find that teenage mothers are at higher risk of NCA, but older mothers 35-44 years are not. However, the maternal age pattern of risk differs between countries, suggesting that it is not biological age that is associated with risk of NCA, but reproductive (including parity and use of Assisted Reproductive Technology), social, ethnic, exposure or lifestyle factors that have a different relationship with maternal age in different European countries. We should therefore expect apparently conflicting results between published studies of different populations, as has indeed been found in the past. This finding is in contrast to the older maternal age-related risks for chromosomal anomalies such as Down's syndrome, which are the same across different countries, indicative of intrinsic biological risk factors. 18, 19 The sharp increase in average maternal age has led to public health concerns over worsening pregnancy outcomes. 20 Our results show that older maternal age is a negligible risk factor for NCAs, especially when compared to chromosomal anomalies. Since the rise in maternal age in Europe is especially associated with women of higher social status, it may have resulted in decreasing NCA risks in this age group compared to past decades. 21 Nevertheless, in some countries, particularly Germany and Poland, older maternal age seems to be a more important risk factor. This may be associated with risk factors more prevalent among these mothers either during the years of the study (2000) (2001) (2002) (2003) (2004) or in their earlier lives. Compared with the middle of the age range (25-29 years), teenage mothers had an 11% excess risk (95%CI 6-17%). This finding is consistent with findings from North America, 3, 22, 23 but some countries (particularly France, Ireland and Portugal) had higher risks than others. Teenage mothers had a five times increased risk (and mothers 20-24 years had double the risk) of maternal infection syndromes compared with mothers aged 25-29 years. Congenital CMV infection accounted for all but two of the 13 maternal infection cases in teenage mothers in our study. Maternal age <25 years and recent onset of sexual activity are known risk factors for CMV. 24 In addition, hydrocephaly, microcephaly and gastroschisis have been associated with maternal infections, 25, 26 and it is possible that higher risks for these malformations among teenage mothers are mediated in part by undiagnosed infection.
The high risk of the abdominal wall defect gastroschisis in young mothers is well known. [4] [5] [6] Although social deprivation, substance abuse, smoking and low body mass index have been indicated by aetiologic studies as risk factors for gastroschisis, a complete explanation of the young maternal age risk has not been found. It may be that these mothers are in addition more biologically vulnerable to these risk factors. Vascular disruption has been proposed as a pathogenic mechanism underlying the risk of certain types of NCA, including gastroschisis, in young mothers, [27] [28] [29] but not all anomalies that have been associated with vascular disruption showed higher risks in teenage mothers in this study.
The high risk of anencephalus, in teenage mothers has previously been reported 3 and may relate to lower folic acid status because of poorer nutrition or lower periconceptional folic acid supplementation rates associated with unplanned pregnancies and lower socioeconomic status. 30 However, the lack of risk in teenage mothers for spina bifida suggests other factors are also important.
Mothers who survived congenital heart defects as infants are now giving birth (although some high risk mothers are advised not to get pregnant), and may be at greater risk of having children with the same or different anomalies. 31, 32 In this regard, the surveillance of prevalence of babies with congenital heart disease among younger mothers is of interest. The finding regarding risks of tricuspid atresia among teenage mothers needs confirmation in further studies, as the risk estimate is based on a small number of cases, but is unlikely to be explained by such a survival effect.
Despite the lack of overall increased risk in older mothers, there were some specific congenital anomaly subgroups which did show a significantly increased risk worthy of comment. Our finding that fetal alcohol syndrome is strongly associated with older maternal age needs further follow up. Fetal alcohol syndrome is underascertained by most congenital anomaly registers as it is often diagnosed after the first year of life and usually does not involve major structural malformations. Our finding, although based on small numbers, could indicate that older mothers are more vulnerable to alcohol effects with respect to malformation risk, or that they are more frequently heavy alcohol consumers periconceptionally, or that their chronic consumption results in different risks from teenage binge drinking, or that they are more likely to be known to clinicians as heavy alcohol consumers. Thanatophoric dwarfism is associated with new mutations known to be related to older paternal age. 33 It is therefore not surprising that we find an effect of older maternal age (35-39 years). There was little statistical power to investigate the over 40-year age group.
Our finding of an increased risk for oesophageal atresia (with or without fistula) among older mothers is consistent with the findings of a Swedish case-control study 1982-2004, 34 but is contrary to an earlier European study which found an increased risk for younger mothers <20 years in 1980-88. 35 This could be indicative of a cohort effect as the older mothers in this study and the younger mothers in the earlier European study were born in the 1960s. The increased risk of encephalocele among older mothers seems also to be counter to previous findings. 3, 36 It must be borne in mind, that inconsistent findings in the literature may be due to chance differences as a result of multiple testing in this and other studies.
The strengths of this study are the large size of the study population combined with high case ascertainment, standardised methodology and specific diagnostic information. However, even in such a large study, there is not sufficient statistical power to examine whether maternal age-specific RR for specific congenital anomaly subgroups vary between countries because of their individual rarity. We would have liked to analyse information in the database on parity-among NCA cases, 80% of teenage mothers were primiparous compared with 55% of mothers 20-24, 46% of mothers 25-29, 34% of mothers 30-34, 23% of mothers 35-39 and 18% of mothers 40+ years. However, there is no comparable population information on parity for most of the populations included. This highlights the importance of developing general perinatal information for Europe. 37 A number of artefacts can lead to small apparent agerelated risk increases. Mismatches between numerator and denominator can bias estimates of risk. For example, we did not correct TOPFA for age at expected delivery, which means that mothers aged 19 that had a TOPFA, may well have been in the 20-24 age group if they had gone to term. This would lead to there being slightly more cases of congenital anomaly in mothers <20 years compared with the corresponding birth population. However, since only 7% of teenage mothers had terminations of pregnancy, and of those 61% were under 19 years, this would not explain excess risk in this age group. For mothers 40-44, lack of age correction of terminations would have underestimated the age-related risk slightly.
Since we only include spontaneous fetal deaths from 20 weeks gestation, it is of course possible that different maternal age effects would be found if all incident cases during pregnancy could be considered, because of differential in utero survival effects. Older mothers have an increased risk of stillbirth and early miscarriage 38, 39 and it is possible that this applies particularly to more vulnerable malformed fetuses. The increased risk of multiple births to mothers [35] [36] [37] [38] [39] years and the increased risk of congenital anomalies among multiple births (5% of our NCA cases were multiple births) also need further investigation in relation to older maternal age risks.
Clinical and public health interventions are needed to reduce environmental risk factors for NCA, giving special attention to young mothers among whom some risk factors are more prevalent. Reassurance can be given to older mothers that their age in itself does not confer extra risk for NCA.
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